Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Your mind is firing on all cylinders today, and with so many thoughts and ideas swirling, it’s a great time to break out of your usual mental patterns. Challenge your existing beliefs and be ...

Fourth Quarter Financial Highlights. On March 12, 2025, the Board of Navigator Holdings Ltd. (NYSE: NVGS) (“Navigator Holdings,” "Na ...